Back to Results
First PageMeta Content
Vaccines / Biology / Vaccination / Malaria vaccine / RTS / S / DNA vaccination / Plasmodium falciparum / Sabin Vaccine Institute / Malaria prophylaxis / Medicine / Health / Malaria


Document Date: 2010-09-28 05:26:06

Open Document

File Size: 157,75 KB

Share Result on Facebook

City

WASHINGTON / DC / Washington / /

Company

GlaxoSmithKline / MVI / Blue Bell / Inovio Pharmaceuticals / Crucell N.V. / Glaxosmithkline plc / /

Continent

Africa / /

Country

Australia / /

/

Event

FDA Phase / Business Partnership / /

Facility

Sabin Vaccine Institute / National Institute of Allergy / Walter Reed Army Institute of Research / Eliza Hall Institute of Medical Research / University of Pennsylvania / /

IndustryTerm

appropriate health technologies / biopharmaceutical / /

MedicalCondition

disease / targeted disease / common cold / minor respiratory infections / Malaria / deadliest malaria / malaria disease / S malaria / human infection / clinical disease / malaria infections / severe disease / serious malaria / /

MedicalTreatment

immunizations / /

Organization

Walter Reed Army Institute of Research / Melinda Gates Foundation / PATH PATH / National Institute of Allergy and Infectious Diseases / United States Agency for International Development / the University of Pennsylvania / Philadelphia / United States Army / Johns Hopkins Bloomberg School of Public Health / Eliza Hall Institute of Medical Research in Melbourne / American Society of Tropical Medicine and Hygiene in Atlanta / Sabin Vaccine Institute / /

Person

David Weiner / Patrick Duffy / S. Ashley Birkett / Christian Loucq / Julie Healer / Preeti Singh / /

/

Position

investigator / director / director of pre / /

Product

GSK / Malaria Vaccine / /

ProvinceOrState

Pennsylvania / /

Region

sub-Saharan Africa / /

Technology

electroporation / appropriate health technologies / antibodies / /

URL

www.malariavaccine.org / www.path.org / /

SocialTag